A secondary analysis of the FINGER lifestyle trial found that baseline dysglycaemia, especially OGTT-derived measures, was associated with less favourable cognitive and brain changes, while HbA1c showed mixed results. PICO summary and expert commentary.
A retrospective secondary analysis clustered app-usage data from 328 pregnant women in a gestational diabetes mHealth trial into three engagement types, with most classified as moderate users. PICO summary and expert commentary.
A multicentre randomised trial found dapagliflozin 10 mg daily for 48 weeks improved biopsy-confirmed MASH without worsening fibrosis in more patients than placebo. PICO summary and expert commentary.
A secondary analysis of a Swedish RCT links higher engagement with a smartphone dietary-education app to modest dietary improvements, with no significant cardiometabolic marker changes, in adults with type 2 diabetes. PICO summary and expert commentary.
A multicentre open-label RCT testing whether 12-month mHealth home telemonitoring improves blood pressure and HbA1c versus standard care in older adults with hypertension and type 2 diabetes. PICO summary and expert commentary.
A 58-patient single-site implementation RCT of the community-health-worker-led TIME programme for uninsured Hispanic adults with type 2 diabetes, with PICO summary and expert commentary.
Three-year REAL4 extension data on once-weekly somapacitan versus daily growth hormone in children with growth hormone deficiency, with PICO summary and expert commentary.
An open-label randomized trial in newly diagnosed type 2 diabetes found acarbose and vildagliptin both lowered plasma TMAO, with a greater fall on acarbose. PICO summary and expert commentary.
An MRI sub-study of the MemAID trial found that 24 weeks of intranasal insulin increased several hippocampal and medio-prefrontal resting-state connectivity measures versus placebo in 11 adults with type 2 diabetes. PICO summary and expert commentary.
A pragmatic RCT testing whether brief telehealth problem-solving therapy (LISTEN) reduces diabetes distress in adults with type 1 and type 2 diabetes versus usual web-based resources. PICO summary and expert commentary.
Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.
© 2024-2026 Hormone Insight. All rights reserved.
